Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase…
Eli Lillys weight loss treatments have powered the company into the top ten list of megacap U.S. stocks.…
Eli Lilly shares tumble as Q3 misses estimates, guidance lowered…
Eli Lilly misses third-quarter profit amid soaring demand for weight-loss drug…
Eli Lilly and Co (NYSE:LLY) shares fell over 12% on Wednesday after the drug maker slashed guidance for the year…
Eli Lilly has a number of lucrative opportunities that should serve as tailwinds for sustained growth.…
9.48am: Stocks open lower, led by S&P and Nasdaq Wall Streets main indices have stumbled in early treading. The Dow…
Eli Lilly has been a huge winner with its GLP-1 drugs.…
Eli Lilly misses third-quarter estimates for earnings and sales. Mounjaro and Zepbound sales also miss estimates. Stock declines 11%.…
Google-parent Alphabet shares climb after cloud revenue boosts earnings, AMD stock drops on a weak sales outlook, and Eli Lilly…
The pharmaceuticals giant has exceeded Wall Streets expectations for five straight quarters, helped by the success of its GLP-1 drugs…
One key disease-prevention market is drawing closer to being within reach.…
One key disease-prevention market is drawing closer to being within reach.…
The odds of its new drug getting established in the U.K. are now much lower.…
The odds of its new drug getting established in the U.K. are now much lower.…
Eli Lilly’s weight-loss drug Mounjaro set for Hong Kong launch - report…
…
Eli Lilly gets nod to launch weight-loss drug in Hong Kong - Bloomberg News…
Stanley Druckenmillers Duquesne Family Office exited its position in Eli Lilly stock last quarter.…
Coming up: Amazon, Exxon, and Eli Lilly earnings, September jobs report, Consumer Spending Inflation, GDP…
Fewer contenders means fewer constraints on expanding market share.…
Fewer contenders means fewer constraints on expanding market share.…
Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound,…
Dallas, Texas, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company…
…
Eli Lilly just secured a huge win, and its not related to the weight loss industry.…
Eli Lilly is investing billions into new research and manufacturing capabilities.…
Eli Lilly is investing billions into new research and manufacturing capabilities.…
Eli Lillys valuation could look much more modest in the future, as its earnings should continue to grow at a…
Eli Lillys valuation could look much more modest in the future, as its earnings should continue to grow at a…
Hims & Hers has enjoyed a rally on an FDA decision regarding Eli Lillys tirzepatide.…
These are two of healthcares biggest darlings right now, but one looks better positioned for the long run.…
These are two of healthcares biggest darlings right now, but one looks better positioned for the long run.…
U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major…
Hims & Hers (NYSE: HIMS) Climbs as FDA to Reconsider Decision Barring Compounded Versions of Eli Lilly (NYSE: LLY) Weight…
Hims & Hers Health (NYSE:HIMS) is up ~10% in Monday morning trading following a recent lawsuit challenging the U.S. FDAs decision to…
INDIANAPOLIS (dpa-AFX) - Der US-Pharmakonzern Eli Lilly hat im zweiten Quartal einen Umsatz- und Ergebnissprung…
INDIANAPOLIS (dpa-AFX) - Der US-Pharmakonzern Eli Lilly hat im zweiten Quartal einen Umsatz- und Ergebnissprung…
WHITE OAK/INDIANAPOLIS (dpa-AFX) - Der US-Arzneimittelhersteller Eli Lilly kann weiter auf eine Zulassung seines Alzheimermittels…
INDIANAPOLIS (dpa-AFX) - Der US-Pharmakonzern Eli Lilly ist dank gut laufender Geschäfte mit Abnehmmitteln mit…
GREIFSWALD (dpa-AFX) - Die Greifswalder Pharmafirma Cheplapharm ist weiter auf Wachstumskurs. Im Geschäftsjahr 2023 sei ein…
INDIANAPOLS (dpa-AFX) - Der US-Arzneimittelhersteller Lilly muss womöglich noch länger auf eine Zulassung seines Alzheimermittels…
NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat das Kursziel für Eli Lilly nach…
INDIANAPOLIS (dpa-AFX) - Nach dem Verkaufsstart seines Abnehmmittels traut sich der Pharmakonzern Eli Lilly 2024…
INDIANAPOLIS (dpa-AFX) - Nach dem Verkaufsstart seines Abnehmmittels traut sich der Pharmakonzern Eli Lilly 2024…
NEW YORK (dpa-AFX) - Aktuelle Daten zum Abnehmmittel Zepbound (Tirzepatide) haben den in diesem Jahr bislang…
NEW YORK (dpa-AFX Broker) - Die Aktien von Eli Lilly sind am Montag nach einem…
(Amt von Hernandez im ersten Absatz korrigiert)
BERLIN (dpa-AFX) - Der US-Pharmakonzern…
(im ersten Satz des dritten Absatzes muss es korrekt Europa heißen. Zudem wurde ein Satz zu Abnehmspritzen…
BERLIN (dpa-AFX) - Der US-Pharmakonzern Eli Lilly will mit mehr als zwei Milliarden Euro eine…